Clover Health Investments, Corp. 2026 Annual Meeting of Stockholders

On June 10, 2026, Clover Health Investments, Corp. held its 2026 Annual Meeting of Stockholders. The stockholders voted on three proposals: the election of three Class II Directors, a non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2025, and the ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. Demetrios L. Kouzoukas, Andrew Toy, and Thomas L. Tran were elected as Class II Directors. The compensation of the Named Executive Officers was approved on an advisory basis. The appointment of Ernst & Young LLP was ratified. The voting results for each proposal are detailed in the filing.